ala-glu-asp-gly · tetrapeptide · pineal bioregulator
your telomeres shorten every year.
your pineal gland produces less melatonin every decade.
your sleep architecture changes in ways that compound quietly.
epithalon addresses what most interventions don't reach.
available by request only
most describe it not as stimulation but as restoration. sleep that arrives differently. mornings that feel less like a negotiation. a quiet but unmistakable shift in how time feels on the body.
epithalon (ala-glu-asp-gly) is a synthetic tetrapeptide developed from the pineal gland extract epithalamin, first isolated in the 1970s by professor vladimir khavinson at the st. petersburg institute of bioregulation and gerontology.
the primary mechanism involves activation of telomerase — the enzyme responsible for maintaining telomere length in somatic cells. published studies document measurable telomere elongation in human somatic cells following epithalon administration.
secondary mechanisms include normalisation of melatonin secretion via restoration of pineal gland activity, modulation of the hypothalamic-pituitary axis, and antioxidant effects documented across multiple tissue models. animal studies show consistent lifespan extension of 10–25% across multiple species.
for research contexts only. key references: khavinson et al. bull exp biol med 2003 · khavinson & morozov, ann n y acad sci 2003. available upon request.
belle labs · epithalon
access is by request only.
€499 per pen
request access →